Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Ramipril 1.25 mg tablet
Dosage Form : Tablet
Packaging Type : blister
Packaging : 10*15
Price : ₹1/-
Ramipil 1.25 Tablet contains Ramipril 1.25 mg, an ACE (Angiotensin-Converting Enzyme) inhibitor that helps manage high blood pressure and heart failure and reduces the risk of stroke and heart attack. It works by relaxing blood vessels, lowering blood pressure, and improving blood flow, thereby easing the strain on the heart. It is also used to delay the progression of kidney disease in diabetic patients with hypertension.
Most patients tolerate Ramipril well. However, some may experience dry cough, dizziness, headache, fatigue, or gastrointestinal discomfort. In rare cases, serious effects like angioedema, hypotension, or kidney function changes may occur. Regular monitoring is advised.
Ramipil 1.5 Tablet is indicated for the treatment of mild to moderate hypertension, congestive heart failure, post-myocardial infarction care, and cardiovascular event risk reduction in high-risk patients. It is also beneficial in slowing down the progression of kidney disorders in diabetic patients.
Use only under medical supervision. Not to be used during pregnancy or in patients with a history of angioedema related to ACE inhibitors. Monitor renal function and electrolytes during therapy. Do not stop the medication abruptly without a doctor’s advice.
Store at a temperature below 30°C, away from moisture and direct sunlight. Keep out of reach of children.
Composition : Prasugrel 10 mg Tablets
Composition : Ramipril 2.5 mg tablet
Composition : Ramipril 5 mg tablet
Composition : Ramipril (10mg) tablet
Composition : Nitroglycerine 2.6 mg Tablet
Composition : Nitroglycerine 6.4 mg Tablet
Composition : Olmesartan Medoxomil (40mg) tablet
Composition : Olmesartan 20 mg + Hydrochlorothiazide 12.50 mg tablet
Composition : Olmesartan 40 mg + hydrochlorothiazide 12.50 mg tablet
Composition : Olmesartan medoxomil 20 mg + amlodipine 5 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation